CHAPTER 1 - MARKET SUMMARY
Market Overview
The Vietnam Medical Devices Market operates through imported original-equipment manufacturers, authorized distributors, public tenders, private hospital contracts and a limited domestic manufacturing base. Demand is anchored by 1,645 hospitals and more than 170 million outpatient visits recorded during 2024, creating recurring requirements for diagnostic imaging, laboratory testing, monitoring, surgical equipment, consumables, maintenance and replacement systems.
Commercial activity is concentrated in Ho Chi Minh City, Hanoi and adjoining industrial and healthcare corridors. These hubs combine tertiary hospitals, private medical groups, regulatory representatives, distributors and biomedical service teams. Vietnam had approximately 31.7 planned hospital beds per 10,000 people in 2022, while metropolitan referral centers handle nationally concentrated demand for advanced imaging, oncology, cardiology and minimally invasive procedures.
Market Value
USD 1,770 million
2025
Dominant Region
Southeast Region
Dominant Segment
Patient Monitoring & Life Support
fastest growing
Total Number of Players
1,450
Future Outlook
The Vietnam Medical Devices Market is projected to increase from USD 1.77 billion in 2025 to USD 2.89 billion by 2031. Historical expansion averaged 7.20% annually during 2020-2025, reflecting hospital modernization, import recovery, private healthcare investment and broader diagnostic access. Forecast growth is expected to accelerate to 8.50% during 2026-2031 as hospitals replace aging installed equipment, marketing authorization procedures stabilize and procurement shifts toward connected monitoring, point-of-care diagnostics, minimally invasive systems and service-supported equipment contracts. Market volume is projected to rise from 512 million weighted device-equivalent units in 2025 to 694 million units by 2031.
Value growth will outpace volume because the product mix is moving toward higher-specification imaging, cardiovascular intervention, critical-care monitoring and digitally connected platforms. Average value per weighted device-equivalent unit is expected to increase from approximately USD 3.46 in 2025 to USD 4.16 by 2031. The base scenario assumes continued import availability, predictable licensing, sustained public tender activity and private hospital expansion. The bear scenario reflects delayed procurement and price pressure, while the bull scenario assumes faster localization, stronger private investment and broader adoption of managed-equipment services, artificial-intelligence-enabled diagnostics and portable systems outside major metropolitan hospitals.
8.50%
Forecast CAGR
$2,886 Mn
2030 Projection
Base Year
2025
Historical Period
2020-2025
Forecast Period
2026-2031
Historical CAGR
7.20%
CHAPTER 2 - SCOPE OF REPORT
Scope of the Market
CHAPTER 3 - Key Stakeholders
Key Target Audience
Key stakeholders who can leverage from this market analysis for investment, strategy, and operational planning.
Investors
CAGR, import substitution, service margins, regulatory exposure, exits
Corporates
tenders, installed base, authorization pipeline, channel productivity, pricing
Government
localization, procurement efficiency, quality compliance, access, resilience
Operators
utilization, uptime, maintenance, consumables planning, clinical workflow
Financial institutions
equipment leasing, receivables, utilization risk, covenant design
CHAPTER 4 - Market Size & Growth
Vietnam Medical Devices Market Size, Share & Forecast, By Product Type, End User & Sales Channel, 2026–2031
Geography: Vietnam | Historical Period: 2020-2025 | Forecast Period: 2026-2031
Historical & Projected Market Size ($ Million)
Year-over-Year Growth Rate (%)
Market Value vs Volume Growth (%)
Historical Market Performance (2020-2025)
Market value increased by USD 520 million between 2020 and 2025. The lowest annual growth occurred in 2021 at 5.2%, reflecting disrupted capital procurement, installation delays and hospital operating constraints. Growth accelerated to 7.6% in 2022 as deferred tenders resumed, moderated to 7.1% in 2023 and reached 8.3% in 2025. The strongest value contribution came from monitoring, diagnostic imaging, laboratory automation and infection-control consumables. Demand remained concentrated in public hospitals, while private hospital groups increased their share of multi-site equipment, service and replacement contracts.
Forecast Market Outlook (2026-2031)
The market is forecast to add USD 1.12 billion between 2025 and 2031, reaching USD 2.89 billion. Forecast value growth of 8.50% will exceed projected volume growth of 5.20%, indicating an increasing contribution from higher-value devices, software-enabled systems and service-supported contracts. Connected devices are projected to represent 26% of value by 2031, compared with 15% in 2025. Expansion will be strongest in patient monitoring, minimally invasive intervention, point-of-care diagnostics and equipment-as-a-service models that reduce upfront capital requirements for hospitals and diagnostic centers.
CHAPTER 5 - Market Data
Market Breakdown
The Vietnam Medical Devices Market is moving from basic replacement procurement toward digitally connected, clinically specialized and service-supported equipment. For CEOs and investors, the central questions are how import exposure, public procurement concentration and connected-device penetration influence market access, working capital, pricing and recurring service revenue.
Year | Market Size (USD Mn) | YoY Growth (%) | Imported Supply Share (%) | Public Hospital Procurement Share (%) | Connected Device Share (%) | Period |
|---|---|---|---|---|---|---|
| 2020 | $1,250 Mn | +- | 92% | 61% | Forecast | |
| 2021 | $1,315 Mn | +5.2% | 92% | 61% | Forecast | |
| 2022 | $1,415 Mn | +7.6% | 91% | 60% | Forecast | |
| 2023 | $1,515 Mn | +7.1% | 91% | 59% | Forecast | |
| 2024 | $1,635 Mn | +7.9% | 90% | 59% | Forecast | |
| 2025 | $1,770 Mn | +8.3% | 90% | 58% | Forecast | |
| 2026 | $1,920 Mn | +8.5% | 89% | 58% | Forecast | |
| 2027 | $2,083 Mn | +8.5% | 89% | 57% | Forecast | |
| 2028 | $2,260 Mn | +8.5% | 88% | 57% | Forecast | |
| 2029 | $2,452 Mn | +8.5% | 88% | 56% | Forecast | |
| 2030 | $2,660 Mn | +8.5% | 87% | 56% | Forecast | |
| 2031 | $2,886 Mn | +8.5% | 86% | 55% | Forecast |
Imported Supply Share
90%, 2025, Vietnam. High import reliance concentrates value in authorization, distribution, inventory financing and technical service. More than 90% of medical equipment and supplies were historically imported, increasing exposure to foreign-exchange movements and registration timing. Source: International Trade Administration, 2023.
Public Hospital Procurement Share
58%, 2025, Vietnam. Tender execution remains critical for imaging, laboratory, intensive-care and surgical suppliers. Vietnam reported 1,645 hospitals in 2024, including 384 private hospitals, leaving public institutions as the largest installed-base and procurement channel. Source: Vietnam Law and Legal Forum, 2025.
Connected Device Share
15%, 2025, Vietnam. Connected monitoring and diagnostic platforms support higher service attachment and recurring software revenue. Noncommunicable diseases account for 80% of deaths in Vietnam, reinforcing demand for longitudinal monitoring, cardiac care and chronic-disease management. Source: World Health Organization, 2025.
CHAPTER 6 - Segmentation
Market Segmentation Framework
Comprehensive analysis across key dimensions providing insights into market structure, consumer preferences, and distribution patterns.
No of Segments
7
Dominant Segment
Product Type
Fastest Growing Segment
Technology
Product Type
Care Setting
End User
Disease Area
Sales Channel
Technology
Operating Model
Key Segmentation Takeaways
Comprehensive analysis across all extracted segmentation dimensions providing insights into market structure, consumer preferences, and distribution patterns.
Product Type
Product selection determines tender structure, import economics, service requirements and supplier concentration. Diagnostic imaging and patient monitoring generate substantial equipment and maintenance revenue, while consumables provide higher purchase frequency. Patient Monitoring & Life Support is the largest growth contributor because hospitals are expanding critical-care capacity, operating rooms and connected bedside monitoring across public and private facilities.
Technology
Technology is the fastest-growing dimension as procurement shifts from standalone equipment toward connected, portable and software-enabled platforms. AI-Enabled Diagnostic Systems and Point-of-Care & Portable Platforms will gain adoption where hospitals need faster workflow, specialist support and broader provincial access. Commercial success depends on interoperability, local-language interfaces, cybersecurity, clinician training and measurable reductions in diagnostic or treatment turnaround time.
CHAPTER 8 - INDUSTRY ANALYSIS
Growth Drivers, Market Challenges & Market Opportunities
Comprehensive analysis of key factors shaping the Vietnam Medical Devices Market, including growth catalysts, operational challenges, and emerging opportunities across production, distribution, and consumer segments.
Growth Drivers
Hospital Modernization and Procedure Growth
- More than 170 million outpatient visits (2024, Vietnam) sustain high-throughput demand for imaging, laboratory testing, patient monitoring and procedure consumables, benefiting suppliers with reliable local inventory and service coverage.
- Over 17 million inpatient treatments (2024, Vietnam) increase utilization of operating-room, intensive-care, anesthesia and infection-control products, strengthening recurring consumables revenue and equipment-replacement cycles.
- The public network includes 47 central, 419 provincial and 684 district hospitals (WHO, Vietnam), supporting tiered product portfolios and provincial service hubs rather than a metropolitan-only commercial strategy.
Chronic Disease and Aging Demand
- Vietnam records approximately 165,000 new cancer cases annually (WHO, Vietnam), supporting imaging, pathology, biopsy, radiotherapy-planning and minimally invasive oncology equipment demand.
- Raised blood pressure affects 40.2% of people aged 50-69 (World Bank study, Vietnam), expanding demand for cardiovascular diagnostics, monitoring and intervention systems.
- Vietnam's aging trajectory will raise hospital use and health expenditure, creating longer-term value pools in home monitoring, rehabilitation, ophthalmology, orthopedics and chronic-care devices.
Insurance Utilization and Regulatory Normalization
- Health-insurance treatment expenditure exceeded VND 101 trillion (2025, Vietnam), strengthening demand for devices linked to reimbursed inpatient, diagnostic and technical services.
- Decree 04/2025/ND-CP effective January 1, 2025 (Vietnam) amended the device-management framework, improving visibility for authorization, import and lifecycle compliance planning.
- Mandatory marketing authorization for Class B, C and D devices from July 1, 2025 (Vietnam) favors suppliers with complete dossiers, qualified local representation and post-market systems.
Market Challenges
Import Dependence and Currency Exposure
- Imports from Japan, Germany, the United States, China and Singapore account for a substantial supply share, limiting buyer leverage during global component shortages and freight disruption.
- High-end imaging, intervention and life-support systems require foreign parts and software, increasing total lifecycle costs for hospitals when exchange rates, service travel or proprietary consumables rise.
- Domestic production contributes only an estimated 10% of market supply (2025, Vietnam), leaving limited local alternatives for advanced systems and creating working-capital pressure for distributors holding imported inventory.
Authorization and Tender Complexity
- The expiration of legacy import-license derogations on June 30, 2025 (Vietnam) increased the cost of incomplete regulatory transition for Class B, C and D portfolios.
- Price declaration, registration-holder obligations and recall responsibilities under Decree 98 increase compliance requirements across importers, distributors and manufacturers.
- Public tender documentation and hospital-level procurement processes can lengthen sales cycles, making regulatory readiness, bid bonds, technical specifications and local references material competitive barriers.
Hospital Financing and Capability Gaps
- Vietnam had an additional unplanned inpatient bed for every three planned beds (2022, Vietnam), indicating capacity pressure that may not be matched by staffing or equipment budgets.
- Advanced systems require biomedical engineers, trained clinicians and preventive maintenance, creating adoption bottlenecks outside major referral centers even where capital funding is available.
- Out-of-pocket expenditure remains above recommended thresholds, limiting affordability for homecare and patient-paid devices unless products are reimbursed, rented or distributed through lower-cost channels.
Market Opportunities
Local Assembly and Consumables Manufacturing
- Investors can target single-use products, tubing, catheters, protective supplies and selected diagnostic consumables where production processes are scalable and recurring demand supports capacity utilization.
- Hospitals and distributors benefit from shorter replenishment cycles, reduced currency exposure and improved tender responsiveness when locally produced items meet quality and registration requirements.
- Localization requires ISO-aligned quality systems, supplier qualification, sterilization capability and regulatory clarity; partnerships with established multinational manufacturers can reduce technology-transfer risk.
Equipment-as-a-Service and Private Hospital Contracts
- Pay-per-procedure, leasing and managed-equipment contracts monetize installed assets while reducing upfront capital requirements for private hospitals and diagnostic centers.
- OEMs, distributors, lessors and financial institutions can capture recurring service, consumables and software revenue by bundling equipment uptime with clinical workflow support.
- Scalable contracts require transparent utilization data, enforceable service-level agreements, credit assessment and reliable reimbursement or patient-volume forecasts.
Connected Monitoring and Point-of-Care Platforms
- Connected monitoring can create subscription, software-license and analytics revenue while enabling hospitals to extend chronic-care oversight beyond inpatient settings.
- Patients, provincial facilities and specialty providers benefit from portable ultrasound, rapid diagnostics and remote monitoring where specialist capacity is geographically concentrated.
- Adoption requires interoperable data standards, cybersecurity, clinician training, validated algorithms and reimbursement mechanisms that recognize remote or digitally supported care.
CHAPTER 9 - Competitive Landscape
Competitive Landscape Overview
The Vietnam Medical Devices Market is fragmented at distribution level but concentrated within advanced imaging, monitoring, intervention and implant categories. Entry barriers include marketing authorization, hospital references, tender eligibility, working capital, trained service engineers and reliable access to replacement parts and consumables.
Market Share Distribution
Top 5 Players
Market Dynamics
8 new entrants in the past 5 years, indicating strong market attractiveness and growth potential.
Company Name | Market Share | Headquarters | Founding Year | Core Market Focus |
|---|---|---|---|---|
GE HealthCare | - | Chicago, United States | - | Diagnostic imaging, ultrasound, patient monitoring and clinical software |
Siemens Healthineers | - | Erlangen, Germany | 2017 | Imaging, laboratory diagnostics, image-guided therapy and service partnerships |
Philips | - | Amsterdam, Netherlands | 1891 | Imaging, ultrasound, monitoring, healthcare informatics and hospital solutions |
Medtronic | - | Dublin, Ireland | 1949 | Cardiovascular, surgical, neurological and minimally invasive technologies |
Abbott | - | Abbott Park, United States | 1888 | Diagnostics, diabetes care, cardiovascular and neuromodulation devices |
Johnson & Johnson MedTech | - | New Brunswick, United States | 1886 | Surgical, orthopedic, cardiovascular and vision-care technologies |
B. Braun | - | Melsungen, Germany | 1839 | Infusion therapy, surgical instruments, dialysis and hospital consumables |
Stryker | - | Kalamazoo, United States | 1941 | Orthopedics, surgical equipment, neurotechnology and emergency-care products |
Olympus | - | Tokyo, Japan | 1919 | Endoscopy, minimally invasive surgery and therapeutic procedure systems |
Terumo | - | Tokyo, Japan | 1921 | Cardiovascular intervention, blood management and hospital consumables |
Cross Comparison Parameters
The report provides detailed cross-comparison of key players across 10 performance parameters to identify competitive strengths and weaknesses.
Installed Base Coverage
Regulatory Authorization Pipeline
Vietnam MedTech Revenue Growth
Service Contract Margin
Analysis Covered
Market Share Analysis:
Estimates category leadership using installed base, tenders and revenue
Cross Comparison Matrix:
Benchmarks players across commercial, operational and financial performance indicators
SWOT Analysis:
Evaluates portfolio strengths, service gaps, exposure and strategic options
Pricing Strategy Analysis:
Compares tender pricing, service bundles and lifecycle economics systematically
Company Profiles:
Reviews portfolio, presence, partnerships, positioning and market access capabilities
CHAPTER 10 - REPORT TOC
Table of Contents
Phase 1Market Assessment Phase
11
Chapters
Supply-side and competitive intelligence covering market sizing, segmentation, competitive dynamics, regulatory landscape, and future forecasts.
Phase 2Go-To-Market Strategy Phase
15
Chapters
Entry strategy evaluation, execution roadmap, partner recommendations, and profitability outlook.
Phase 3Survey Phase
8
Chapters
Demand-side primary research conducted through structured interviews and online surveys with end users across priority metros and Tier 2/3 cities to capture consumption behavior, unmet needs, and purchase drivers.
Complete Report Coverage
201+ detailed sections covering every aspect of the market
143
Assessment Sections
58
Strategy Sections
CHAPTER 11 - Our Approach
Research Methodology
Desk Research
- Medical-device authorization database review
- Hospital procurement and tender tracking
- Healthcare utilization indicator analysis
- Medical-device trade-flow assessment
Primary Research
- Hospital procurement directors interviewed
- Biomedical engineering managers interviewed
- Medical-device distributors interviewed
- Regulatory affairs managers interviewed
Validation and Triangulation
- 370 respondent observations validated
- Supplier revenue estimates reconciled
- Import and consumption values compared
- Hospital utilization assumptions stress-tested
CHAPTER 12 - FAQ
FAQs
Still have questions?
Our research team is here to help you find the right solution
CHAPTER 13 - Related Research
Explore Related Reports
Expand your market intelligence with complementary research across regions and adjacent markets.
Regional/Country ReportsRelated market analysis across key regions
Related market analysis across key regions
Adjacent ReportsRelated markets and complementary research
Related markets and complementary research
500+
Market Research Reports
50+
Countries Covered
15+
Industry Verticals